Article

[Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea].

Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
The Korean Journal of Hepatology 04/2009; 15(1):25-41. DOI: 10.3350/kjhep.2009.15.1.25
Source: PubMed

ABSTRACT The purpose of this study was to evaluate the cost-effectiveness of 1 year and up to 5 years of antiviral treatment for chronic hepatitis B (CHB).
Two ten-health-state Markov models were developed for CHB patients. The proportion of patients remaining alive in each health state, and healthcare costs and quality-adjusted life years (QALYs) were determined during annual cycles of these Markov models. The total healthcare costs, life years, and QALYs over the 40-year time horizon of the model were calculated. The perspectives of the cost-effectiveness analysis were the Korean healthcare system and the healthcare needs of the CHB patient.
Short-course therapy with alpha-interferon or 1-year treatment with pegylated interferon alpha-2a, lamivudine (LMV), or adefovir (ADV) had limited impact on disease progression. In contrast, either LMV-ADV or ADV-LMV as rescue medication administered for 5 years resulted in a more sustained decrease in the rate of disease progression. The cost-effectiveness threshold in Korea was estimated to be approximately 25,000,000 South Korean won. LMV administered for 1 year is cost-effective in comparison with no treatment for both HBeAg-positive and HBeAg-negative CHB patients, but longer duration antiviral therapies administered for up to 5 years in CHB patients were found to be highly cost-effective by international standards.
Antiviral treatment of CHB with LMV or ADV for up to 5 years using the alternative antiviral agent as rescue medication appears to be a cost-effective strategy for both HBeAg-positive and HBeAg-negative CHB patients in Korea. Economic evaluation of antiviral therapies should be studied further and updated, particularly for newer agents.

0 Bookmarks
 · 
249 Views
  • Source
    The Korean journal of hepatology. 12/2011; 17(4):258-60.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bifidobacteria are considered one of the most beneficial probiotics and have been widely studied for their effects in preventing and treating specific pathological conditions. The present study explored the antiviral activity of Bifidobacterium adolescentis SPM0212 isolated from healthy Koreans against hepatitis B virus (HBV) and its mechanism of action. To determine the effect of B. adolescentis SPM0212 against HBV, the level of HBV surface antigen (HBsAg) in the culture medium and the levels of viral transcripts in HepG2.2.15 cells were measured by enzyme-linked immunosorbent assay and reverse transcription-quantitative PCR (RT-qPCR), respectively. To clarify the mechanism, we performed RT-qPCR using specific primers for genes encoding Interferon (IFN)-signaling components and IFN-inducible antiviral effectors. The cell extract of B. adolescentis SPM0212 dose-dependently decreased the extracellular HBsAg level by up to 50 %. Its gene expression in HepG2.2.15 cells was also inhibited by 40 %. This extract significantly increased the expression level of myxovirus resistance A, which is an IFN-inducible antiviral effector. Furthermore, the antiviral activity was observed in the fraction of compound(s) with molecular weights under 30 kDa. Thus, the cell extract of B. adolescentis SPM0212 inhibits HBV and its antiviral mechanism is associated with the Mx GTPase pathway.
    Archives of Pharmacal Research 05/2013; · 1.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In recent years second-order cascading effects in non-centrosymmetric crystals have drawn much attention not only in the context of basic understanding of the nonlinear optical processes but also potential applications in all-optical devices such as optical switches and transistors. Since the amount of phase change due to the second-order cascading is proportional to the square of the effective d-value, organic crystals with large second-order susceptibilities, such as 3-methyl-4-methoxy-4-nitrostilbene (MMONS) are of great interest in this respect. MMONS crystals show one of the largest second-order susceptibilities and the effective d-value was measured to be d<sub>eff </sub>=38 pm/V at 1.064 μm by Maker fringe technique
    Nonlinear Optics '98: Materials, Fundamentals and Applications Topical Meeting; 09/1998

Full-text

View
1 Download
Available from